Patients with HCC have been shown by Ormandy et al. to exhibit heightened numbers of CD4+CD25+ Tregs in their peripheral blood, accompanied by increased GITR expression on these Tregs, both within the tumor microenvironment and systemically [85]. This evidence concerns the gene TNFRSF18 and neoplasm.